PANTHERx® Specialty Pharmacy is honored to announce our sponsorship of the Soft Bones International Scientific Meeting to promote education and advocacy for hypophosphatasia (HPP). This meeting will host the thought leaders and treatment experts in hypophosphatasia from across the world to promote research of this rare bone disease through awareness and fundraising efforts. The Inaugural […]

Gene therapy isn’t on the horizon anymore; it’s here.  Precision medicine demands a level of personalization that few Specialty Pharmacies are equipped to handle.  PANTHERx®’s pure focus on rare and orphan conditions has propelled the company to the forefront of the industry for program personalization, making it the ideal partner to bring new gene therapies […]

PANTHERx® Specialty Pharmacy is pleased to announce that it has received full reaccreditation from URAC, pursuant to Specialty Pharmacy, Version 3.0. This accreditation is a reflection of PANTHERx®’s unwavering commitment to Uncompromising Quality in our patient care. “It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are […]

PANTHERx® Specialty Pharmacy, The Rare Disease SP®, is honored to be the recipient of the 2018 APPA “Specialty Pharmacy of the Year Award” and Chairman & CEO, Dr. Gordon J. Vanscoy, will be accepting this recognition and presenting the keynote speech on Rare Disorders and Orphan Drugs at the upcoming APPA PharmaCon Expo from June […]